Principal Financial Group’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,555
| Closed | -$173K | – | 2238 |
|
|
2024
Q2 | $173K | Sell |
18,555
-570
| -3% | -$5.3K | ﹤0.01% | 2163 |
|
|
2024
Q1 | $190K | Buy |
19,125
+705
| +4% | +$6.99K | ﹤0.01% | 2186 |
|
|
2023
Q4 | $59.5K | Buy |
18,420
+3,336
| +22% | +$10.8K | ﹤0.01% | 2317 |
|
|
2023
Q3 | $80.1K | Buy |
15,084
+148
| +1% | +$786 | ﹤0.01% | 2312 |
|
|
2023
Q2 | $142K | Buy |
14,936
+1,553
| +12% | +$14.8K | ﹤0.01% | 2233 |
|
|
2023
Q1 | $147K | Sell |
13,383
-979
| -7% | -$10.8K | ﹤0.01% | 2233 |
|
|
2022
Q4 | $213K | Buy |
14,362
+2,654
| +23% | +$39.3K | ﹤0.01% | 2179 |
|
|
2022
Q3 | $223K | Buy |
11,708
+621
| +6% | +$11.8K | ﹤0.01% | 2176 |
|
|
2022
Q2 | $236K | Buy |
+11,087
| New | +$236K | ﹤0.01% | 2249 |
|
|
2021
Q4 | – | Sell |
-9,951
| Closed | -$238K | – | 2536 |
|
|
2021
Q3 | $238K | Sell |
9,951
-1,611
| -14% | -$38.5K | ﹤0.01% | 2382 |
|
|
2021
Q2 | $316K | Buy |
+11,562
| New | +$316K | ﹤0.01% | 2339 |
|